ReleaseWire Connect

Turkey has emerged as one of the most popular destinations in Europe for medical tourism. The country’s medical tourism industry has unprecedentedly grown during the past few years. Being a source as well as destination market, the Turkish medical tourism industry revenue is expected to increase manifold in the coming years. According to our research report “Emerging Medical Tourism in Turkey” the medical tourism market in Turkey is expected to grow at a CAGR of around 16% during 2010-2013. Our research reveals that standardized facilities are one of the major factors that are driving the turkish medical tourism industry.

LPG consumption in India is expected to grow at a CAGR of around 9% during FY 2011–FY 2013, says RNCOS in its new research report.

The market of seasonal influenza vaccines is anticipated to grow at a CAGR of around 11% during 2009-2012, says RNCOS in its latest research report.

Consumption of wine in the US is expected to grow at a CAGR of over 3% during 2010-2013, says RNCOS in its research report.

According to our new research report “Global In Vitro Diagnostic Market Analysis”, the year-on-year growth of the global IVD services industry is anticipated to accelerate in near future, on the back of strong demand for diagnostics services globally.

According to our latest research report “UAE Healthcare Sector Forecast to 2012”, the UAE healthcare industry has been growing at a fast pace for the past few years. The industry’s stupendous growth rate can be attributed to various factors such as, regulatory support, high investments towards infrastructure development, rising population, and increasing cases of numerous chronic and lifestyle diseases. Additionally, the ease of procuring health insurance in the country has been a major factor in the growth of the healthcare industry.

Owing to enhanced private investments, Brazil’s healthcare industry is expected to grow at a CAGR of around 14.5% during 2010-2013, says RNCOS in its research report.

The Indian prepaid credit market is expected to grow on account of favorable government regulations, says a new research report from RNCOS.

With major blockbuster drugs getting expired in coming days, the US generics market is expected to grow at the CAGR of 10% during 2010-2013, says RNCOS.

The global proteomics market is estimated to grow at a CAGR of around 20% during 2011 - 2013, says a new research report from RNCOS.